Medigen Vaccine Biologics (6547): Gewinn- und Verlustrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 58,8 Dollar (TWD) | 72,2 Dollar (TWD) | 33,5 Dollar (TWD) |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 102 Dollar (TWD) | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 328.749.000 | - | - |
Kennzahl in 1000 TWD | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
Umsatz | 613.171 | 605.637 | 389.624 | 365.042 | 3.280.994 | 11.507 | 1.120 |
Herstellungskosten | 248.497 | 209.215 | 168.478 | 577.644 | 975.961 | 3.871 | - |
Bruttoergebnis | 364.674 | 396.422 | 221.146 | -212.602 | 2.305.033 | 7.636 | 1.120 |
▸ Brutto-Marge | 59,47% | 65,46% | 56,76% | -58,24% | 70,25% | 66,36% | 100% |
Betriebliche Aufwendungen | 630.365 | 542.088 | 1.434.975 | 1.235.083 | 888.756 | 665.497 | 599.712 |
Operativer Gewinn/Verlust | -265.691 | -145.666 | -1.213.829 | -1.447.685 | 1.416.277 | -657.861 | -598.592 |
▸ Operative Marge | -43,33% | -24,05% | -311,54% | -396,58% | 43,17% | -5.717,05% | -53.445,71% |
Zinsen (Netto) | 20.496 | 27.360 | 45.711 | -19.283 | -3.279 | -14.942 | -19.126 |
▸ Zinsausgaben | 8.802 | 18.890 | 37.571 | 26.888 | 6.019 | 16.419 | 19.126 |
▸ Zinseinnahmen | 29.298 | 46.250 | 83.282 | 7.605 | 2.740 | 1.477 | - |
Andere Ausgaben | 36.519 | -37.841 | -8.283 | 7.605 | 2.740 | 1.477 | - |
Gewinn vor Steuern | -281.714 | -80.465 | -1.159.835 | -1.474.573 | 1.410.258 | -674.280 | -617.718 |
Steueraufwand | - | - | 0,001 | 26.888 | 6.019 | 16.419 | 19.126 |
Minderheitenanteil | - | - | -0,001 | -26.888 | -6.019 | -16.419 | -19.126 |
Nettogewinn/-verlust | -281.714 | -80.465 | -1.159.835 | -1.474.573 | 1.410.258 | -674.280 | -617.718 |
▸ Netto-Marge | -45,94% | -13,29% | -297,68% | -403,95% | 42,98% | -5.859,74% | -55.153,39% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.